[Chronic myeloid leukemia. Diagnosis, course, prognosis].
Lacotte-Thierry
L
L
Département d'hématologie et oncologie médicale, CHU La Milétrie, Poitiers.
Guilhot
F
F
D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D003937:Diagnosis, Differential; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D015465:Leukemia, Myeloid, Accelerated Phase / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D011379:Prognosis; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D007372:Interferons